Cargando…

S9. NEUROIMAGING AND NEUROPHYSIOLOGY BIOMARKERS OF SCHIZOTYPAL PERSONALITY DISORDER: A SYSTEMATIC REVIEW

BACKGROUND: Schizotypal personality disorder (SPD) is a cluster A personality disorder affecting 1.0% of general population, characterised by disturbances in cognition and reality testing dimensions, affect regulation, and interpersonal function. SPD shares similar but attenuated phenomenological, g...

Descripción completa

Detalles Bibliográficos
Autores principales:	Attademo, Luigi, Bernardini, Francesco, Verdolini, Norma
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Poster Session I
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7234122/ http://dx.doi.org/10.1093/schbul/sbaa031.075

Ejemplares similares

S61. COMPUTATIONAL MODELLING OF VISUAL MOTION PERCEPTION AND ITS ASSOCIATION WITH SCHIZOTYPAL TRAITS
por: Farkas, Kinga, et al.
Publicado: (2020)

S75. PERFORMANCE IN WORKING MEMORY AND EXECUTIVE FUNCTIONS AS IT RELATES TO THEORY OF MIND ABILITIES IN A NONCLINICAL SAMPLE OF INDIVIDUALS WITH SCHIZOTYPAL TRAITS
por: Grimes, Kyrsten, et al.
Publicado: (2020)

M239. ENVIRONMENTAL POLLUTION AND RISK FOR PSYCHOTIC DISORDERS: AN UPDATE
por: Pauselli, Luca, et al.
Publicado: (2020)

S229. THE EFFECT OF FAMILY ENVIRONMENT ON LONGITUDINAL FUNCTIONING IN FIRST PSYCHOTIC EPISODES
por: Verdolini, Norma, et al.
Publicado: (2020)

T113. CATEGORICAL AND DIMENSIONAL APPROACHES EXAMINING THE JOINT EFFECT OF AUTISM AND SCHIZOTYPAL PERSONALITY DISORDER ON SUSTAINED ATTENTION
por: Abu-Akel, Ahmad, et al.
Publicado: (2020)

Cognitive Processes and Resting-State Functional Neuroimaging Findings in High Schizotypal Individuals and Schizotypal Personality Disorder Patients: A Systematic Review
por: Zouraraki, Chrysoula, et al.
Publicado: (2023)

Neurophysiological evidence of impaired self-monitoring in schizotypal personality disorder and its reversal by dopaminergic antagonism
por: Rabella, Mireia, et al.
Publicado: (2016)

S168. THE ASSOCIATION BETWEEN MMP-9 AND CHOROID PLEXUS VOLUME IN SCHIZOPHRENIA
por: Seethaler, Magdalena, et al.
Publicado: (2020)

S210. COMPARATIVE EFFECTIVENESS OF ANTIPSYCHOTICS FOR RISK OF ATTEMPTED OR COMPLETED SUICIDE AMONG PERSONS WITH SCHIZOPHRENIA
por: Taipale, Heidi, et al.
Publicado: (2020)

M236. AN ASSESSMENT OF THE DIMENSIONALITY OF A ROMANIAN TRANSLATION OF THE SCHIZOTYPAL PERSONALITY QUESTIONNAIRE AND ASSOCIATIONS WITH QUALITY OF LIFE, SELF-ESTEEM, AND LIFE SATISFACTION
por: Barron, David, et al.
Publicado: (2020)

S63. CLINICAL AND DEVELOPMENTAL CHARACTERISTICS OF COGNITIVE SUBGROUPS IN A TRANSDIAGNOSTIC SAMPLE OF SCHIZOPHRENIA, SCHIZOAFFECTIVE DISORDER AND BIPOLAR DISORDER
por: Bora, Emre, et al.
Publicado: (2020)

S105. DIGITAL BIOMARKERS FOR THE ASSESSMENT OF COGNITIVE, BEHAVIORAL AND FUNCTIONAL OUTCOMES IN INDIVIDUALS WITH SCHIZOPHRENIA
por: Lindenmayer, Jean-Pierre, et al.
Publicado: (2020)

S19. THE ROLE OF ACE AS POSSIBLE BIOMARKER FOR TREATMENT RESISTANCE TO ANTIPSYCHOTICS IN FIRST EPISODE OF PSYCHOSIS
por: Luisa, Longo, et al.
Publicado: (2020)

S73. RELATIONSHIP OF COGNITIVE ABILITY AND PERSONALITY TRAITS WITH HOSTILE ATTRIBUTION BIAS IN NONCLINICAL SUBJECTS: THEORY OF MIND AS A MEDIATOR
por: Jun Koo, Se, et al.
Publicado: (2020)

S11. PLASMA LEPTIN AND ANTHRANILIC ACID IN SCHIZOPHRENIA PATIENTS: NEW BIOMARKERS OF PREDISPOSITION TO METABOLIC ABNORMALITIES
por: Steiner, Johann, et al.
Publicado: (2020)

S31. ENHANCEMENT OF SYNAPTIC PLASTICITY BY COMBINATION OF PDE2 AND PDE9 INHIBITION PRESUMABLY VIA PRE- AND POST-SYNAPTIC MECHANISMS
por: Rosenbrock, Holger, et al.
Publicado: (2020)

S128. IMPACT OF COMORBIDITIES ON SURVIVAL ESTIMATE FOR PATIENTS WITH MENTAL DISORDERS
por: Gonçalves de Rezende, Marcos, et al.
Publicado: (2020)

S82. REINFORCEMENT LEARNING IMPAIRMENT IN PATIENTS WITH EARLY-STAGE PSYCHOTIC BIPOLAR DISORDER
por: Kwun Nam Chan, Joe, et al.
Publicado: (2020)

S133. DIAGNOSED SPEECH, SCHOLASTIC AND MOTOR DISORDERS AS PREDICTORS FOR NON-AFFECTIVE PSYCHOSES
por: Gyllenberg, David, et al.
Publicado: (2020)

S169. THE IMPACT OF PSYCHOSIS IN ADOLESCENT-ONSET BIPOLAR DISORDER: A STRUCTURAL MRI STUDY
por: Llach, Cristian, et al.
Publicado: (2020)

S58. COMPARISON OF FACE EMOTIONAL RECOGNITION DEFICITS IN REMITTED SCHIZOPHRENIA AND BIPOLAR I DISORDER
por: Won, Seunghee, et al.
Publicado: (2020)

S20. LIFETIME PSYCHOPATHOLOGY IN CHILD AND ADOLESCENT OFFSPRING OF PARENTS DIAGNOSED WITH SCHIZOPHRENIA OR BIPOLAR DISORDER
por: De la Serna, Elena, et al.
Publicado: (2020)

The association of hypertensive disorders of pregnancy with severe acute respiratory syndrome coronavirus 2 infection
por: Gulersen, Moti, et al.
Publicado: (2022)

S165. GLUTAMATERGIC ABNORMALITIES IN EARLY SCHIZOPHRENIA AND BIPOLAR DISORDER MEASURED USING WHOLE-BRAIN SPECTROSCOPY
por: Lenroot, Rhoshel, et al.
Publicado: (2020)

S134. INCIDENCE, IMPACT AND TRAJECTORIES OF PSYCHOTIC EXPERIENCES FROM CHILDHOOD TO ADULTHOOD, AND PREDICTION OF PSYCHOTIC DISORDER
por: Zammit, Stanley, et al.
Publicado: (2020)

S173. GENOME-WIDE ASSOCIATION STUDIES OF SCHIZOPHRENIA AND BIPOLAR DISORDER IN A DIVERSE COHORT OF US VETERANS
por: Bigdeli, Tim, et al.
Publicado: (2020)

S130. ALTERNATIVE METRICS TO QUANTIFY PREMATURE MORTALITY IN MENTAL DISORDERS. A POPULATION-BASED COHORT STUDY
por: Weye, Nanna, et al.
Publicado: (2020)

S57. CHARACTERIZING COGNITIVE HETEROGENEITY IN INDIVIDUALS WITH A SCHIZOPHRENIA SPECTRUM DISORDER: A CLUSTER ANALYTIC APPROACH
por: Brand, Bodyl
Publicado: (2020)

S42. QUALITATIVE ANALYSIS OF CLINICIANS’ PERSPECTIVES ON THE USE OF A COMPUTERIZED DECISION AID IN THE TREATMENT OF PSYCHOTIC DISORDERS
por: Roebroek, Lukas, et al.
Publicado: (2020)

S176. A PRELIMINARY INVESTIGATION OF COMT GENE INVOLVEMENT IN COGNITIVE FLEXIBILITY AND ATTENTION IN SCHIZOPHRENIA SPECTRUM DISORDERS
por: Morris, Kim, et al.
Publicado: (2020)

S116. PRAGMATIC COMPREHENSION IN SCHIZOPHRENIA: A SYSTEMATIC REVIEW AND META-ANALYSIS
por: Parola, Alberto, et al.
Publicado: (2020)

S202. PROXIMAL AND DISTAL FACTORS ASSOCIATED WITH CLOZAPINE EXPOSURE IN A SAMPLE OF TREATMENT RESISTANT AND TREATMENT RESPONSIVE SCHIZOPHRENIA PATIENTS
por: Barone, Annarita, et al.
Publicado: (2020)

S104. VALIDATION OF THE INDIVIDUAL RECOVERY OUTCOMES COUNTER (I.ROC) IN PEOPLE WITH A SCHIZOPHRENIA SPECTRUM DISORDER IN THE NETHERLANDS
Publicado: (2020)

S41. RANDOMISED CONTROLLED TRIAL OF METACOGNITIVE TRAINING COMPARED WITH PSYCHOEDUCATION IN PATIENTS WITH SCHIZOPHRENIA SPECTRUM DISORDERS: EFFECTS ON INSIGHT
por: Lopez-Morinigo, Javier-David, et al.
Publicado: (2020)

S54. THE RELATION OF FORMAL THOUGHT DISORDER WITH COGNITIVE FUNCTIONS, GLOBAL AND SOCIAL FUNCTIONING AND QUALITY OF LIFE IN PATIENTS WITH SCHIZOPHRENIA
por: Mutlu, Emre, et al.
Publicado: (2020)

S100. INCORRECT DIAGNOSIS OF FIRST EPISODE SCHIZOPHRENIA: IMPACT OF ANXIETY AND THOUGHT DISORDER, AND THE VALUE OF A CONSULTATION CLINIC
Publicado: (2020)

S222. A SYSTEMATIC AND METHODOLOGICAL REVIEW OF RECENT SOCIAL FUNCTIONING MEASURES AND APPROACHES
por: Long, Maria, et al.
Publicado: (2020)

S178. SHOULD SCHIZOAFFECTIVE DISORDER DEPRESSED-TYPE BE DISTINCT FROM SCHIZOPHRENIA? ANALYSIS OF GENETIC LIABILITY AND LIFETIME CLINICAL CHARACTERISTICS
por: Dennison, Charlotte, et al.
Publicado: (2020)

S86. THE RISK OF PHYSICAL HEALTH MULTIMORBIDITY IN PATIENTS WITH PSYCHOSIS: SYSTEMATIC REVIEW AND META-ANALYSIS
por: Rodrigues, Myanca, et al.
Publicado: (2020)

S85. MANAGEMENT OF PHYSICAL HEALTH FOR PEOPLE WITH SCHIZOPHRENIA IN PRIMARY CARE: A SYSTEMATIC REVIEW
por: Wiener, Joshua, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hukssjrcmgkh3nnh93mvh58kpe